Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Curry

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Neuro-Oncology|November 10, 2011
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cellsHiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, et al.
Journal of Neuro-Oncology|July 24, 2012
Prospective, high-throughput molecular profiling of human gliomasAndrew S Chi, Tracy T Batchelor, Dora Dias-Santagata, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 9, 2023
Cases of familial idiopathic normal pressure hydrocephalus implicate genetic factors in disease pathogenesisAna B W Greenberg, Neel H Mehta, Kedous Y Mekbib, et al.
World Neurosurgery|October 2, 2019
Navigable Channel-Based Trans-Sulcal Resection of Third Ventricular Colloid Cysts: A Multicenter Retrospective Case Series and Review of the LiteratureMichelle Lin, Joshua Bakhsheshian, Ben Strickland, et al.
Neuro-Oncology|November 25, 2015
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological gradeWilliam L Hwang, Ariel E Marciscano, Andrzej Niemierko, et al.
Neuro-Oncology|June 7, 2022
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experienceAnurag Saraf, Torunn I Yock, Andrzej Niemierko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers|July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant GliomaMasih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology|September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and miceLeland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Neuro-Oncology|November 10, 2011
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cellsHiroaki Wakimoto, Gayatry Mohapatra, Ryuichi Kanai, et al.
Journal of Neuro-Oncology|July 24, 2012
Prospective, high-throughput molecular profiling of human gliomasAndrew S Chi, Tracy T Batchelor, Dora Dias-Santagata, et al.
Cancer Immunology, Immunotherapy : CII|October 9, 2025
Intratumoral B cell and interferon signatures in newly diagnosed glioblastoma are associated with longer survival in patients treated with SurVaxMHenry G Withers, Sheila A Figel, Jingxin Qiu, et al.
Cerebral Cortex (New York, N.Y. : 1991)|October 9, 2023
Cases of familial idiopathic normal pressure hydrocephalus implicate genetic factors in disease pathogenesisAna B W Greenberg, Neel H Mehta, Kedous Y Mekbib, et al.
World Neurosurgery|October 2, 2019
Navigable Channel-Based Trans-Sulcal Resection of Third Ventricular Colloid Cysts: A Multicenter Retrospective Case Series and Review of the LiteratureMichelle Lin, Joshua Bakhsheshian, Ben Strickland, et al.
Neuro-Oncology|November 25, 2015
Imaging and extent of surgical resection predict risk of meningioma recurrence better than WHO histopathological gradeWilliam L Hwang, Ariel E Marciscano, Andrzej Niemierko, et al.
Neuro-Oncology|June 7, 2022
Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experienceAnurag Saraf, Torunn I Yock, Andrzej Niemierko, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatmentDaniel P Cahill, Kymberly K Levine, Rebecca A Betensky, et al.
Cancers|July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant GliomaMasih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology|September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and miceLeland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Pageof 25